Literature DB >> 3181272

Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512).

L M Ching1, B C Baguley.   

Abstract

Flavone acetic acid (FAA), an antitumour agent currently undergoing clinical trials, was found to augment the tumoricidal activity of peritoneal exudate (PE) cells in vitro. Lysis of tumour targets was measured using a standard 18 h 51Cr release assay for activated macrophages. Lytic activity increased with increasing concentrations of FAA up to 100 micrograms/ml before reaching a plateau. At 80 micrograms/ml FAA, 3-fold fewer PE cells were necessary to obtain the same level of activity as in control cultures without FAA. The lytic activity was mediated by Thy-1 negative and glass-adherent cells in the PE population, and was inhibited by dexamethasone. The activity of PE cells against several different tumour targets (P815 mastocytoma, YAC-1 lymphoma, P388 lymphoma, and a Lewis lung carcinoma cell line) were all enhanced by FAA. The results show that FAA can enhance the lytic potential of peritoneal macrophages in vitro to kill a range of tumour cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181272     DOI: 10.1016/0277-5379(88)90345-8

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  8 in total

1.  Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.

Authors:  M Philpott; B C Baguley; L M Ching
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

2.  Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours.

Authors:  L M Ching; W R Joseph; L Zhuang; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels.

Authors:  L J Zwi; B C Baguley; J B Gavin; W R Wilson
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

4.  Flavone acetic acid--an interesting novel therapeutic agent or just another disappointment?

Authors:  M C Bibby
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

5.  Necrosis in non-tumour tissues caused by flavone acetic acid and 5,6-dimethyl xanthenone acetic acid.

Authors:  L J Zwi; B C Baguley; J B Gavin; W R Wilson
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

6.  Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice.

Authors:  L M Ching; W R Joseph; B C Baguley
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

7.  Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.

Authors:  M C Bibby; R M Phillips; J A Double; G Pratesi
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

8.  Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.

Authors:  D R Newell; K M Searle; N B Westwood; S S Burtles
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.